CyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsPhosphoramide MustardsVincristineDoxorubicinAntineoplastic Agents, AlkylatingTreatment OutcomePrednisoneImmunosuppressive AgentsCombined Modality TherapyMethotrexateDrug Administration SchedulePulse Therapy, DrugEtoposideEpirubicinBusulfanFollow-Up StudiesTime FactorsThiotepaBreast NeoplasmsRetrospective StudiesPrednisoloneRemission InductionAntibodies, Monoclonal, Murine-DerivedSurvival RateSurvival AnalysisProspective StudiesPatient SelectionFluorouracilDrug Therapy, CombinationRecurrenceLeukopeniaVidarabineBone Marrow TransplantationGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinDisease-Free SurvivalTransplantation, AutologousDose-Response Relationship, DrugAnticoagulantsVena Cava FiltersMethylprednisoloneFeasibility StudiesCystitisAdministration, MetronomicWhole-Body IrradiationDrug LabelingHematopoietic Stem Cell TransplantationChemotherapy, AdjuvantCarmustineTransplantation ConditioningMelphalanTransplantation, HomologousImmunosuppressionAzathioprineWegener GranulomatosisLupus NephritisInfusions, IntravenousThrombolytic TherapyPrognosisMesnaIfosfamideCisplatinRisk FactorsAntineoplastic AgentsNonprescription DrugsAdministration, OralNeutropeniaChlorambucilNeoplasm StagingAcroleinMitoxantroneRisk AssessmentBleomycinWarfarinPractice Guidelines as TopicAlkylating AgentsHematopoietic Stem Cell MobilizationAge FactorsLiver TransplantationClinical Trials as TopicAtrial AppendagePilot ProjectsLeukocyte CountProcarbazineGraft SurvivalPostoperative ComplicationsAnemia, AplasticDexamethasoneCytarabinePaclitaxelLymphoma, Large B-Cell, DiffusePulmonary EmbolismAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisTomography, X-Ray ComputedCarboplatinFibrinolytic AgentsAdrenergic beta-AntagonistsContraceptives, Oral, CombinedAtrial Fibrillation